Cargando…
Artemisia Annua sublingual immunotherapy for seasonal allergic rhinitis: A multicenter, randomized trial
BACKGROUND: Artemisia annua is the most common outdoor aeroallergen throughout Northern China; however, no multicenter study has investigated sublingual immunotherapy (SLIT) as a treatment option for Artemisia annua-induced allergic rhinitis (AR). The aim of this study was to evaluate the efficacy a...
Autores principales: | Lou, Hongfei, Wang, Xueyan, Wei, Qingyu, Zhao, Changqing, Xing, Zhimin, Zhang, Qinna, Meng, Juan, Zhang, Shaoqiang, Zhou, Huifang, Ma, Ruixia, Zhang, Hua, Liu, Hui, Xue, Weiguo, Wang, Chengshuo, Zhang, Luo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7490724/ https://www.ncbi.nlm.nih.gov/pubmed/32963688 http://dx.doi.org/10.1016/j.waojou.2020.100458 |
Ejemplares similares
-
Sublingual immunotherapy in allergic rhinitis
por: Han, Doo Hee, et al.
Publicado: (2011) -
Omalizumab is effective in the preseasonal treatment of seasonal allergic rhinitis
por: Zhang, Yuan, et al.
Publicado: (2022) -
Comparison of Long-term Efficacy of Subcutaneous Immunotherapy in Pediatric and Adult Patients With Allergic Rhinitis
por: Huang, Yanran, et al.
Publicado: (2018) -
Pharmacoeconomics of sublingual immunotherapy with the 5-grass pollen tablets for seasonal allergic rhinitis
por: Lombardi, Carlo, et al.
Publicado: (2017) -
Sublingual or Subcutaneous immunotherapy for Seasonal Allergic Rhinitis (AR): an indirect analysis of efficacy, safety and cost
por: Dranitsaris, George, et al.
Publicado: (2014)